No Data
No Data
Xingxin New Material (SZ. 001358): The company's products are currently not applied to vitamins.
Xingxin New Materials (001358.SZ) stated on the investor interaction platform on August 6 that the company's products are currently not used for vitamins.
Xingxin New Materials (001358.SZ): has repurchased 0.28% of its shares.
On August 1st, Geeronghui announced that Xingxin New Materials (001358.SZ) had cumulatively repurchased 348,954 shares through centralized bidding trading as of July 31, 2024, accounting for 0.28% of the company's current total share capital. The highest transaction price was 19.00 yuan/share, the lowest transaction price was 18.08 yuan/share, and the total transaction amount was 6,501,351.36 yuan (excluding transaction fees).
Xingxin New Material (001358.SZ): The company currently does not have photoresist products.
On July 26th, Gelunhui reported that Xingxin New Materials (Stock Code: 001358.SZ) stated on the investor's interactive platform that the company's products such as N-hydroxyethylpiperazine and N,N-dimethylacrylamide are important components of photoresist stripping liquid, but the company currently does not produce photoresist products.
Xingxin New Material (001358.SZ): First repurchased 0.0545 million shares.
On July 18th, GeLongHui reported that Xingxin New Material (001358.SZ) announced that on July 18, 2024, the company repurchased 0.0545 million shares of its own stock for the first time through the stock repurchase dedicated securities account by centralized bidding trading, accounting for 0.04% of the total current share capital of the company. The highest transaction price was 18.53 yuan/share, the lowest transaction price was 18.08 yuan/share, and the total trading amount was 998,076.00 yuan (excluding transaction fees).
Shaoxing Xingxin New Materials: 2024 Interim Performance Forecast
Xingxin New Materials (001358.SZ): net income in the first half of the year is expected to decrease by 50.66%-54.90%.
Xingxin New Materials (001358.SZ) announced its performance forecast for the first half of 2024, with a net income attributable to shareholders of the listed company of CNY 42.5 million to CNY 46.5 million, a decrease of 50.66% to 54.90% year-on-year. After deducting non-recurring gains and losses, the net income attributable to shareholders of the listed company was CNY 38.5 million to CNY 42.5 million, a decrease of 54.19% to 58.50% YoY. The basic earnings per share are CNY 0.34 to CNY 0.38 per share. During the reporting period, the company's net income decreased compared with the same period last year, mainly due to the company's raw materials, including six.
No Data